364 related articles for article (PubMed ID: 23256798)
1. Immunotherapy for head and neck cancer patients: shifting the balance.
Turksma AW; Braakhuis BJ; Bloemena E; Meijer CJ; Leemans CR; Hooijberg E
Immunotherapy; 2013 Jan; 5(1):49-61. PubMed ID: 23256798
[TBL] [Abstract][Full Text] [Related]
2. [Research progress in pathogenesis, treatment and prognosis of HPV positive head and neck squamous cell carcinoma].
Shui CY; Li C; Liu W; Cai YC; Jiang J; Sun RH; Zhou YQ; Qin G
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):392-396. PubMed ID: 29764025
[TBL] [Abstract][Full Text] [Related]
3. New insights into human papillomavirus-associated head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Del Mistro A; Bussu F; Lupato V; Baboci L; Almadori G; DA Mosto MC; Paludetti G
Acta Otorhinolaryngol Ital; 2013 Apr; 33(2):77-87. PubMed ID: 23853396
[TBL] [Abstract][Full Text] [Related]
4. Relationship of human papillomavirus with diseases of the oral cavity.
Boguñá N; Capdevila L; Jané-Salas E
Med Clin (Barc); 2019 Aug; 153(4):157-164. PubMed ID: 31109717
[TBL] [Abstract][Full Text] [Related]
5. The New Face of Head and Neck Cancer: The HPV Epidemic.
Lewis A; Kang R; Levine A; Maghami E
Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.
Ragin CC; Modugno F; Gollin SM
J Dent Res; 2007 Feb; 86(2):104-14. PubMed ID: 17251508
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the head and neck is the sixth most common cancer worldwide.
Duvvuri U; Myers JN
Curr Probl Surg; 2009 Feb; 46(2):114-7. PubMed ID: 19111678
[No Abstract] [Full Text] [Related]
9. Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany.
Quabius ES; Haag J; Kühnel A; Henry H; Hoffmann AS; Görögh T; Hedderich J; Evert M; Beule AG; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Tribius S; Röcken C; Ambrosch P; Hoffmann M
Int J Oncol; 2015 Jan; 46(1):414-22. PubMed ID: 25310104
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus therapeutic vaccines in head and neck tumors.
Badaracco G; Venuti A
Expert Rev Anticancer Ther; 2007 May; 7(5):753-66. PubMed ID: 17492938
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of human papillomavirus-related head and neck cancer.
Joseph AW; D'Souza G
Otolaryngol Clin North Am; 2012 Aug; 45(4):739-64. PubMed ID: 22793850
[TBL] [Abstract][Full Text] [Related]
12. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
13. [Human papillomavirus and squamous cell cancer of the head and neck region : Prognostic, therapeutic and prophylactic implications].
Reuschenbach M; Wagner S; Würdemann N; Sharma SJ; Prigge ES; Sauer M; Wittig A; Wittekindt C; von Knebel Doeberitz M; Klussmann JP
HNO; 2016 Jul; 64(7):450-9. PubMed ID: 26864190
[TBL] [Abstract][Full Text] [Related]
14. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
[TBL] [Abstract][Full Text] [Related]
15. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
Vermorken JB
Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
[TBL] [Abstract][Full Text] [Related]
17. DNA-based immunotherapy for HPV-associated head and neck cancer.
Aggarwal C
Immunotherapy; 2016 Oct; 8(10):1187-92. PubMed ID: 27605067
[TBL] [Abstract][Full Text] [Related]
18. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
Näsman A; Bersani C; Lindquist D; Du J; Ramqvist T; Dalianis T
Anticancer Res; 2017 Oct; 37(10):5319-5328. PubMed ID: 28982840
[TBL] [Abstract][Full Text] [Related]
20. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
